CoreCap Advisors LLC Acquires 399 Shares of CME Group Inc. (NASDAQ:CME)

CoreCap Advisors LLC raised its stake in CME Group Inc. (NASDAQ:CME) by 15.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,996 shares of the financial services provider’s stock after acquiring an additional 399 shares during the quarter. CoreCap Advisors LLC’s holdings in CME Group were worth $696,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in CME. SJS Investment Consulting Inc. boosted its stake in shares of CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 97 shares in the last quarter. New Age Alpha Advisors LLC boosted its position in CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after buying an additional 43 shares during the period. Financial Life Planners bought a new stake in CME Group during the 4th quarter worth approximately $32,000. Knuff & Co LLC acquired a new position in CME Group in the 4th quarter valued at approximately $33,000. Finally, Fortitude Family Office LLC raised its stake in shares of CME Group by 120.3% during the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after acquiring an additional 83 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, insider Derek Sammann sold 4,650 shares of the firm’s stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $280.61, for a total value of $1,304,836.50. Following the transaction, the insider now owns 8,336 shares in the company, valued at $2,339,164.96. This trade represents a 35.81 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Julie Winkler sold 11,592 shares of the company’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the sale, the insider now owns 21,885 shares of the company’s stock, valued at $5,453,085.45. This trade represents a 34.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 34,726 shares of company stock worth $8,975,813 in the last quarter. Insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on CME shares. UBS Group boosted their price objective on shares of CME Group from $290.00 to $305.00 and gave the stock a “buy” rating in a research note on Friday, April 25th. Royal Bank of Canada restated a “sector perform” rating and set a $269.00 price objective on shares of CME Group in a research report on Thursday, April 3rd. Keefe, Bruyette & Woods upped their target price on CME Group from $265.00 to $273.00 and gave the company a “market perform” rating in a report on Thursday, April 24th. Raymond James upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price target for the company in a report on Monday, March 10th. Finally, Barclays upped their price objective on shares of CME Group from $279.00 to $283.00 and gave the company an “equal weight” rating in a research note on Wednesday, April 23rd. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $256.80.

CME Group Stock Performance

Shares of CME Group stock opened at $284.35 on Friday. The business has a 50-day simple moving average of $264.47 and a 200 day simple moving average of $245.55. The firm has a market capitalization of $102.47 billion, a price-to-earnings ratio of 29.41, a PEG ratio of 6.76 and a beta of 0.45. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. CME Group Inc. has a one year low of $190.70 and a one year high of $286.48.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping analysts’ consensus estimates of $2.61 by $0.19. The company had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a return on equity of 13.62% and a net margin of 57.52%. CME Group’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the prior year, the firm earned $2.50 earnings per share. On average, research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be issued a $1.25 dividend. The ex-dividend date of this dividend is Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.76%. CME Group’s dividend payout ratio is presently 50.30%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.